Epigenetic modifications as novel therapeutic targets for Huntington's disease.
about
Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels.Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced NeurotoxicityContribution of Neuroepigenetics to Huntington's Disease.Multiregional analysis of global 5-methylcytosine and 5-hydroxymethylcytosine throughout the progression of Alzheimer's disease.[Epigenetic regulations and cerebral plasticity: towards new therapeutic options in neurodegenerative diseases?]
P2860
Epigenetic modifications as novel therapeutic targets for Huntington's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Epigenetic modifications as novel therapeutic targets for Huntington's disease.
@en
Epigenetic modifications as novel therapeutic targets for Huntington's disease.
@nl
type
label
Epigenetic modifications as novel therapeutic targets for Huntington's disease.
@en
Epigenetic modifications as novel therapeutic targets for Huntington's disease.
@nl
prefLabel
Epigenetic modifications as novel therapeutic targets for Huntington's disease.
@en
Epigenetic modifications as novel therapeutic targets for Huntington's disease.
@nl
P2093
P2860
P356
P1433
P1476
Epigenetic modifications as novel therapeutic targets for Huntington's disease.
@en
P2093
Caixia Guo
Fengli Wang
Paula L Fischhaber
Tie-Shan Tang
P2860
P304
P356
10.2217/EPI.14.19
P577
2014-06-01T00:00:00Z